A Study to Assess the Efficacy and Safety of Burfiralimab(hzVSF-v13) and OAD (Oral Antiviral Drug)

Clinical trial NCT05808335 · UNKNOWN

Trial details

NCT number: NCT05808335
Sponsor: ImmuneMed, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2022-01-11
Primary completion: 2024-03-27
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.